News

Clinical Trials Arena5h

Diakonos initiates dosing in Phase II trial of glioblastoma treatment

Diakonos Oncology has dosed the first subject in its Phase II trial of DOC1021 for treating glioblastoma (GBM).
Clinical Trials Arena7h

Arch Biopartners’ Phase II AKI prevention trial begins patient recruitment

Arch Biopartners has initiated subject recruitment in its Phase II study aimed at assessing cilastatin in preventing AKI.